grepafloxacin has been researched along with Bronchitis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breisch, S; Chodosh, S; Lakshminarayan, S; Swarz, H | 1 |
| Amantea, MA; Chodosh, S; Collins, DA; Forrest, A; Schentag, JJ | 1 |
| Breisch, S; Cranfield, R; Langan, CE; Pettit, R | 1 |
| Friis, HM | 1 |
| Bagby, B; Bettis, R; Collins, JJ; DeAbate, CA; Fleming, H; Giguere, G; Munk, ZM; Munn, NJ; Riffer, E | 1 |
| Langan, CE; Marr, C; McIvor, A; Peirzchala, W; Smakal, M; Staley, H; Vogel, F; Zuck, P | 1 |
| Ballow, CH; Forrest, A; Hyatt, JM; Peloquin, CA; Sands, MF; Schentag, JJ; Tran, JQ | 1 |
| Chodosh, S; Forrest, A; Hyatt, JM; Meinl, B; Schentag, JJ | 1 |
6 trial(s) available for grepafloxacin and Bronchitis
| Article | Year |
|---|---|
Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Bronchodilator Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Theophylline; Treatment Outcome | 1998 |
Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Male; Middle Aged; Models, Biological; Piperazines; Quinolones; Time Factors | 1997 |
Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Hematologic Tests; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Piperazines; Quinolones; Treatment Outcome | 1997 |
Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Quinolones | 1999 |
Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchitis; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines | 1999 |
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchitis; Chronic Disease; Clarithromycin; Female; Fluoroquinolones; Haemophilus; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Piperazines; Serum Bactericidal Test; Sputum | 2000 |
3 other study(ies) available for grepafloxacin and Bronchitis
| Article | Year |
|---|---|
New antibiotic approved for community-acquired infections.
Topics: Anti-Infective Agents; Bronchitis; Community-Acquired Infections; Contraindications; Fluoroquinolones; Humans; Piperazines; Pneumonia; Quinolones; Sexually Transmitted Diseases; United States; United States Food and Drug Administration | 1998 |
[Grepafloxacin (Raxar)].
Topics: Anti-Infective Agents; Bronchitis; Contraindications; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperazines; Pneumonia; Quinolones; Urethritis; Uterine Cervicitis | 1998 |
Pharmacokinetic/pharmacodynamic predictors of time to clinical resolution in patients with acute bacterial exacerbations of chronic bronchitis treated with a fluoroquinolone.
Topics: Anti-Infective Agents; Bronchitis; Chronic Disease; Controlled Clinical Trials as Topic; Female; Fluoroquinolones; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Piperazines; Predictive Value of Tests; Treatment Outcome | 2000 |